CORESTEMCHEMON Inc.

₩1,587As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:166480Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (16.64%)
Div yield —
ROE (61.95%)
Biological Products, Except Diagnostic Substances
Beta (5Y) 1.67
PE TTM —
TSR TTM 2.39%
Mkt cap ₩70.40B
ROIC (26.05%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩1,628
2.56%
(46.29%)
Buy 12|10|4|0|0
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
15.30
14.69
14.21
13.63
8.52%
3.23%
(7.92%)
(13.87%)
Revenue₩B
4.461
4.415
4.464
4.429
(2.13%)
(0.78%)
(1.31%)
0.19%
Peers (US$51.90M)
Cap (US$)
PE
54.82M
—
54.82M
11.40x
45.74M
8.277x
Capital
TTM
5Y
10Y
Leveragex
0.701
0.763
0.629
EBIT/Intx
0.869
0.080
0.077
Own earn%
(65.83)
(23.60)
(22.51)
Sh yield%
34.33
0.83
3.41
Owners
Insiders/Inst%
11.62
49.55
Short interest%
1.91
SBC / revenue%
1.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
20–24
$1 testx
−0.1
Incr. ROIC%
3